Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Brain Neoplasms 8Breast Neoplasms 4Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Central Nervous System Diseases 1Breast Diseases 1

Interventions

selpercatinib 2alectinib 2tucatinib 1trametinib 1pamiparib 1glutathione pegylated liposomal doxorubicin 1entrectinib 1elacestrant 1dabrafenib 1cobimetinib 1capmatinib 1abemaciclib 1Vemurafenib 1Trastuzumab 1Radiation 1RAD1901 1Pemetrexed 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × tucatinib × CNS × Clear all
NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available
BreastCNS

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡